Research Groups
Clinical Trial Group
Lead: Prof Fahal
Coordinator: Dr. Eiman Saddig
Double-blind, randomised clinical trial for eumycetoma treatment using fosravuconazole versus the current standard of care, daily treatment with itraconazole.
MRC- DNDi – Eisai Ltd (Japan) Group Members
Diagnostics Research Group
Lead: Dr. Sahar Mubarak
Subgroups
Development of field-friendly point-of-care diagnostic test for mycetoma
MycEXomics Members
Protein Biobank
MRC – Biochemistry Department, Faculty of Medicine, U of K Group Members
Eumycetoma Molecular Diagnosis
MRC – Erasmus Medical Centre Group Members
Actinomycetoma Molecular Diagnosis
MRC – Erasmus Medical Centre Group Members
In Vitro Drugs Sensitivity Testing
MRC – Erasmus Medical Centre Group Members
Fosravuconazole Pharmacodynamics for Eumycetoma Treatment
MRC – DNDi
Epidemiology Research Group
Lead: Prof Fahal
Coordinator: Dr. Sahar Mubarak
Mycetoma Environment Microorganisms Spatial Distribution
MRC, Mycetoma AMED Group
Mycetoma Genetics
Mycetoma spatial distribution at Eastern Sennar
MRC – Nagasaki University, Japan Group Members
Mycetoma Transmission Route and Vector Control
MRC – Vector Genetics and Control Laboratory, Faculty of Science, University of Khartoum Group Members
Mycetoma Spatial Distribution in Sudan
MRC – Faculty of Geographical and Environmental Sciences, University of Khartoum Group Members
Social Sciences Research Group
Lead: Dr Azza Ahmed A AZZIZ
Immunopathology Research Group
Lead: Prof. Ahmed Mudawi Musa
Coordinator: Dr. Sahar Mubarak
Digital Spatial Profiling of the immune- microenvironment in the mycetoma granulomas
MRC – Immunity and Infection Centre, York University
Immune responses of mycetoma patients during a double-blind, randomised clinical trial for eumycetoma treatment using fosravuconazole versus the current standard of care, daily treatment with itraconazole.
MRC- DNDi – Eisai Ltd (Japan) Group Members
Mycetoma Mathematical Modeling
Lead: Prof. Fahal
Coordinator: Miss Hayman Omer
The mathematical modelling for the histopathological diagnosis of Mycetoma
MRC – Tours University, France Group Members
The mathematical modelling for the mycetoma treatment outcome
MRC, Comboni University College
Coordinator: Miss Hayman Omer
Drug Repurposing for Mycetoma
MRC – Tours University, France Group Members
Coordinator: Dr Lamis EL Khair
Global Mycetoma Epidemiological Survey
Lead: Dr Dallas Smith
Centers for Diseases Control, DNDi, MRC
Mycetoma Immunopathological Study
MRC, Global Mycetoma Working Group